Boehringer takes on antimicrobial resistance with Evotec, bi...

A Franco-German joint venture company – Aurobac Therapeutics – has been formed to try to tackle the rising threat of antimicrobial resistant (AMR) infections.

BMS pays $200m to expand Evotec alliance on protein degrader...

Bristol-Myers Squibb's Celgene unit has clearly been impressed by progress in its four-year-old alliance with Evotec on protein degradation.

Vifor joins forces with Evotec on kidney disease joint ventu...

Evotec announces potential $850m R&D partnership with Takeda

Germany’s Evotec has announced another high-profile R&D partnership with big pharma, beginning a multi-year R&D partnership with Takeda, focusing on discovering small molecule drugs

Evotec begins new Oxford Uni digital health partnership

Germany’s Evotec has begun a new strategic partnership with the British AI tech company Sensyne Health and Oxford University to translate research into new companies working on digital heal

Evotec and Celgene unite to drive forward oncology R&D

Evotec and Celgene have joined forces in a long-term strategic drug discovery and development partnership, to identify new therapeutics in oncology.